CORZ
Core Scientific, Inc.
18.10$
+0.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +25.7% | +26.3% | -21.3% | -32.4% | -0.4% | -16.2% | -1.1% | +3.1% | -1.7% | +44.5% | +42.5% | – | |
| – | +5.3% | -1.0% | +0.6% | -6.6% | -5.6% | -20.9% | +3.2% | +5.1% | -23.7% | +44.9% | +10.1% | – | |
| – | +154.9% | +97.6% | -50.0% | -100.4% | – | +72.4% | -38.8% | -24.9% | +453.1% | +42.4% | +135.5% | – | |
| – | -16.7% | -4.1% | +20.8% | +30.7% | +76.6% | – | – | – | – | – | – | – | |
| – | +3.1% | -30.2% | +55.1% | +30.9% | +3.9% | +24.8% | +27.8% | +21.8% | -76.7% | +179.1% | +9.3% | – | |
| – | +28.8% | -36.6% | +43.8% | +27.4% | +8.5% | +24.0% | -43.3% | +121.1% | -88.6% | +578.7% | +165.8% | – | |
| – | – | +1,303.8% | -88.1% | -726.5% | – | – | – | – | – | -282.6% | – | – | |
| – | +3,721.5% | -83.2% | +4.9% | -52.1% | -83.9% | +92.5% | -45.8% | -30.7% | +11.6% | +430.2% | +390.7% | – | |
| – | – | – | -481.6% | – | – | – | -262.5% | – | – | -261.8% | – | – | |
| – | +194.7% | -38.7% | -30.1% | -6.9% | +179.9% | -45.3% | -22.9% | -20.9% | -24.0% | +531.6% | +217.8% | – | |
| – | – | – | -482.0% | – | – | – | -262.6% | – | – | -262.1% | – | – | |
| – | – | – | -85.0% | -1,191.9% | – | – | -100.1% | – | – | -245.7% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.